U.S. Physical Therapy (USPH) Panoramica del titolo
U.S. Physical Therapy, Inc. insieme alle sue consociate, opera e gestisce cliniche di terapia fisica ambulatoriale. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 3/6 |
| Crescita futura | 3/6 |
| Prestazioni passate | 1/6 |
| Salute finanziaria | 4/6 |
| Dividendi | 3/6 |
Premi
Analisi del rischio
USPH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di U.S. Physical Therapy, Inc.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$72.54 |
| Massimo di 52 settimane | US$93.50 |
| Minimo di 52 settimane | US$58.19 |
| Beta | 1.14 |
| Variazione di 1 mese | 10.65% |
| Variazione a 3 mesi | -7.40% |
| Variazione di 1 anno | -2.63% |
| Variazione a 3 anni | -39.53% |
| Variazione a 5 anni | -34.93% |
| Variazione dall'IPO | 2,901.65% |
Notizie e aggiornamenti recenti
Articolo di analisi • Jun 20
U.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) is back in focus after recent financial disclosures showed 7.89% year-over-year revenue growth and net profit rising 115.29%, while analyst opinions and technical signals currently point in different directions for the stock. See our latest analysis for U.S. Physical Therapy. Despite the latest revenue and net profit figures, U.S. Physical Therapy’s 1-year total shareholder return declined 12.6% and the 5-year total shareholder return fell 41.7%, indicating fading...
Aggiornamento della narrazione • Jun 13
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have lowered their price target on U.S. Physical Therapy to $90 from $103, citing somewhat lower profitability expectations and a higher projected net debt load following a mixed Q1 report. What's in the News From January 1, 2026 to March 31, 2026, U.S. Physical Therapy reported no share repurchases, with 0 shares bought for US$0 million under its existing buyback program (Key Developments).Aggiornamento della narrazione • May 30
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.Seeking Alpha • May 22
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaRecent updates
Articolo di analisi • Jun 20
U.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) is back in focus after recent financial disclosures showed 7.89% year-over-year revenue growth and net profit rising 115.29%, while analyst opinions and technical signals currently point in different directions for the stock. See our latest analysis for U.S. Physical Therapy. Despite the latest revenue and net profit figures, U.S. Physical Therapy’s 1-year total shareholder return declined 12.6% and the 5-year total shareholder return fell 41.7%, indicating fading...Aggiornamento della narrazione • Jun 13
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have lowered their price target on U.S. Physical Therapy to $90 from $103, citing somewhat lower profitability expectations and a higher projected net debt load following a mixed Q1 report. What's in the News From January 1, 2026 to March 31, 2026, U.S. Physical Therapy reported no share repurchases, with 0 shares bought for US$0 million under its existing buyback program (Key Developments).Aggiornamento della narrazione • May 30
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.Seeking Alpha • May 22
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaArticolo di analisi • Sep 12
These 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Articolo di analisi • Aug 02
Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...Articolo di analisi • Jul 11
U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Articolo di analisi • Jun 10
Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Articolo di analisi • May 14
Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Articolo di analisi • Mar 24
Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...Articolo di analisi • Mar 01
U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...Articolo di analisi • Feb 28
U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Articolo di analisi • Jan 03
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Articolo di analisi • Nov 09
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Nuova narrazione • Sep 14
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.Articolo di analisi • Aug 07
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Articolo di analisi • Jul 17
U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Jun 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Articolo di analisi • May 21
There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...Articolo di analisi • May 11
U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Articolo di analisi • May 05
Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Articolo di analisi • Apr 21
A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Articolo di analisi • Apr 07
Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...Articolo di analisi • Mar 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Articolo di analisi • Dec 23
The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Articolo di analisi • Dec 07
Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...Rendimenti per gli azionisti
| USPH | US Healthcare | US Mercato | |
|---|---|---|---|
| 7D | 0.3% | -0.4% | 0.8% |
| 1Y | -2.6% | 31.5% | 20.6% |
Ritorno vs Industria: USPH ha avuto una performance inferiore rispetto al US Healthcare che ha registrato un rendimento 31.5 % nell'ultimo anno.
Rendimento vs Mercato: USPH ha avuto una performance inferiore al mercato US che ha registrato un rendimento 20.6 % nell'ultimo anno.
Volatilità dei prezzi
| USPH volatility | |
|---|---|
| USPH Average Weekly Movement | 7.8% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Prezzo delle azioni stabile: USPH non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 8% ) di USPH è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1990 | 6,374 | Chris Reading | www.usph.com |
U.S. Physical Therapy, Inc. insieme alle sue consociate, opera e gestisce cliniche di terapia fisica ambulatoriale. Opera attraverso due segmenti, Physical Therapy Operations e Industrial Injury Prevention Services. L'azienda fornisce assistenza e trattamento pre e post-operatorio per disturbi ortopedici, lesioni sportive, cure preventive, riabilitazione di lavoratori infortunati e lesioni neurologiche.
U.S. Physical Therapy, Inc. Riepilogo dei fondamenti
| USPH statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$1.10b |
| Utili (TTM) | US$7.67m |
| Ricavi(TTM) | US$787.69m |
144.0x
Rapporto P/E1.4x
Rapporto P/SUSPH è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| USPH Conto economico (TTM) | |
|---|---|
| Ricavi | US$787.69m |
| Costo del fatturato | US$615.17m |
| Profitto lordo | US$172.52m |
| Altre spese | US$164.85m |
| Utili | US$7.67m |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
Aug 06, 2026
| Utile per azione (EPS) | 0.50 |
| Margine lordo | 21.90% |
| Margine di profitto netto | 0.97% |
| Rapporto debito/patrimonio netto | 26.2% |
Come si è comportato USPH nel lungo periodo?
Vedi performance storica e confrontoDividendi
2.5%
Rendimento attuale del dividendo358%
Rapporto di remunerazioneAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/07/12 09:50 |
| Prezzo dell'azione a fine giornata | 2026/07/10 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; disponiamo inoltre di guide su come utilizzare i nostri report e di tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
U.S. Physical Therapy, Inc. è coperta da 15 analisti. 7 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |